CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
About this episode
Dr. Paul G Richardson discusses the function and future role of CELMoDs in treating multiple myeloma.
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma. CME information and select publications here .
More episodes of Hematologic Oncology Update
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
- Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
- CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
- Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
- CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
- Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.